The global epoetin alfa erythropoietin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Epoetin-alpha is a reused form of human erythropoietin. It is originally developed as an intravenous drug for the treatment of anemia in patients with chronic kidney disease and cancer with chemotherapy or radiotherapy. The increase in […]
